Sucrose prevents protein fibrillation through compaction of the tertiary structure but hardly affects the secondary structure
暂无分享,去创建一个
Gunna Christiansen | D. Otzen | Eduardo P Melo | Carlos Lopes | Evandro Tavares | Daniel E Otzen | Henri G. Franquelim | G. Christiansen | Henri G Franquelim | Joana A Macedo | Nídia Estrela | E. Melo | J. A. Macedo | E. Tavares | C. Lopes | Nídia Estrela
[1] Carl Frieden,et al. Quantitative analysis of the time course of Aβ oligomerization and subsequent growth steps using tetramethylrhodamine-labeled Aβ , 2013, Proceedings of the National Academy of Sciences.
[2] S. Kanba,et al. Mechanism for retardation of amyloid fibril formation by sugars in Vλ6 protein , 2013, Protein science : a publication of the Protein Society.
[3] D. Otzen,et al. Stabilization of the ribosomal protein S6 by trehalose is counterbalanced by the formation of a putative off-pathway species. , 2005, Journal of molecular biology.
[4] L. Gierasch,et al. Inhibition of protein aggregation in vitro and in vivo by a natural osmoprotectant , 2006, Proceedings of the National Academy of Sciences.
[5] M. Sierks,et al. Trehalose differentially inhibits aggregation and neurotoxicity of beta-amyloid 40 and 42 , 2005, Neurobiology of Disease.
[6] P. Klemm,et al. Three fim genes required for the regulation of length and mediation of adhesion of Escherichia coli type 1 fimbriae , 1987, Molecular and General Genetics MGG.
[7] D. Otzen,et al. Salt-induced detour through compact regions of the protein folding landscape. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[8] J. T. Gerig,et al. TMAO promotes fibrillization and microtubule assembly activity in the C-terminal repeat region of tau. , 2006, Biochemistry.
[9] P. Taboada,et al. Existence of different structural intermediates on the fibrillation pathway of human serum albumin. , 2009, Biophysical journal.
[10] Jesper Søndergaard Pedersen,et al. Modulation of S6 fibrillation by unfolding rates and gatekeeper residues. , 2004, Journal of molecular biology.
[11] Syamal Roy,et al. A small molecule chemical chaperone optimizes its unfolded state contraction and denaturant like properties , 2013, Scientific Reports.
[12] D. Rubinsztein,et al. Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy. , 2006, Human molecular genetics.
[13] T. Matsuo. Trehalose protects corneal epithelial cells from death by drying , 2001, The British journal of ophthalmology.
[14] J. Kelly,et al. Hydration and packing are crucial to amyloidogenesis as revealed by pressure studies on transthyretin variants that either protect or worsen amyloid disease. , 2003, Journal of molecular biology.
[15] V. Uversky,et al. Conformational constraints for amyloid fibrillation: the importance of being unfolded. , 2004, Biochimica et biophysica acta.
[16] V. Uversky,et al. Trimethylamine‐N‐oxide‐induced folding of α‐synuclein , 2001 .
[17] I. Roy,et al. Effect of trehalose on protein structure , 2008, Protein science : a publication of the Protein Society.
[18] V. Hilser,et al. The enthalpy change in protein folding and binding: Refinement of parameters for structure‐based calculations , 1996, Proteins.
[19] P. Fraser,et al. Manipulating the Amyloid-β Aggregation Pathway with Chemical Chaperones* , 1999, The Journal of Biological Chemistry.
[20] J. McLaurin,et al. Contribution of simple saccharides to the stabilization of amyloid structure. , 2005, Biochemical and biophysical research communications.
[21] S. N. Timasheff. Solvent stabilization of protein structure. , 1995, Methods in molecular biology.
[22] T. Ikegami,et al. Heat of supersaturation-limited amyloid burst directly monitored by isothermal titration calorimetry , 2014, Proceedings of the National Academy of Sciences.
[23] S. Doglia,et al. The osmolyte betaine promotes protein misfolding and disruption of protein aggregates , 2009, Proteins.
[24] Daniel E. Otzen,et al. The Effect of Osmolytes on Protein Fibrillation , 2012, International journal of molecular sciences.
[25] A J Wand,et al. Local dynamics and stability of apocytochrome b562 examined by hydrogen exchange. , 1998, Biochemistry.
[26] D. Turk,et al. Amyloid fibril formation by human stefins: Structure, mechanism & putative functions. , 2010, Biochimie.
[27] D. Otzen,et al. We find them here, we find them there: Functional bacterial amyloid , 2008, Cellular and Molecular Life Sciences.
[28] D. Otzen,et al. Conformational plasticity in folding of the split beta-alpha-beta protein S6: evidence for burst-phase disruption of the native state. , 2002, Journal of molecular biology.
[29] E. Wahle,et al. Hofmeister salts and potential therapeutic compounds accelerate in vitro fibril formation of the N-terminal domain of PABPN1 containing a disease-causing alanine extension. , 2008, Biochemistry.
[30] M. Proctor,et al. Structural changes in the transition state of protein folding: alternative interpretations of curved chevron plots. , 1999, Biochemistry.
[31] R. Riek,et al. Biology of amyloid: structure, function, and regulation. , 2010, Structure.
[32] R. Pappu,et al. Unmasking the roles of N- and C-terminal flanking sequences from exon 1 of huntingtin as modulators of polyglutamine aggregation , 2013, Proceedings of the National Academy of Sciences.
[33] Wei Wang,et al. Protein aggregation and its inhibition in biopharmaceutics. , 2005, International journal of pharmaceutics.
[34] D. Otzen,et al. Thermodynamics and mechanism of cutinase stabilization by trehalose , 2008, Biopolymers.
[35] Yogendra Pratap Singh,et al. Amyloid peptides and proteins in review. , 2007, Reviews of physiology, biochemistry and pharmacology.
[36] G. Rose,et al. Structure and energetics of the hydrogen-bonded backbone in protein folding. , 2008, Annual review of biochemistry.
[37] T. Good,et al. Two disaccharides and trimethylamine N-oxide affect Abeta aggregation differently, but all attenuate oligomer-induced membrane permeability. , 2009, Biochemistry.
[38] Tobin R Sosnick,et al. The folding of single domain proteins--have we reached a consensus? , 2011, Current opinion in structural biology.
[39] M. Sierks,et al. Ectoine and hydroxyectoine inhibit aggregation and neurotoxicity of Alzheimer's β‐amyloid , 2005, FEBS letters.
[40] K. Chattopadhyay,et al. Role of Protein Stabilizers on the Conformation of the Unfolded State of Cytochrome c and Its Early Folding Kinetics , 2010, The Journal of Biological Chemistry.
[41] D. Ejima,et al. Small molecule pharmacological chaperones: From thermodynamic stabilization to pharmaceutical drugs. , 2006, Biochimica et biophysica acta.
[42] C. Ross,et al. Protein aggregation and neurodegenerative disease , 2004, Nature Medicine.
[43] G. McRae,et al. Osmolyte controlled fibrillation kinetics of insulin: New insight into fibrillation using the preferential exclusion principle , 2009, Biotechnology progress.
[44] N. Nukina,et al. Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease , 2004, Nature Medicine.
[45] Shaomin Li,et al. Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory , 2008, Nature Medicine.
[46] Daniel E. Otzen,et al. Conformational plasticity in folding of the split β-α-β protein S6: evidence for burst-phase disruption of the native state , 2002 .
[47] S. Singh,et al. Measuring and modeling hemoglobin aggregation below the freezing temperature. , 2013, The journal of physical chemistry. B.
[48] Eduardo P Melo,et al. Compacting proteins: pros and cons of osmolyte-induced folding. , 2010, Current protein & peptide science.
[49] Julian P. Whitelegge,et al. Initiation and elongation in fibrillation of ALS-linked superoxide dismutase , 2008, Proceedings of the National Academy of Sciences.
[50] Miguel A R B Castanho,et al. An overview of the biophysical applications of atomic force microscopy. , 2003, Biophysical chemistry.
[51] I. Kanazawa,et al. Chemical Chaperones Reduce Aggregate Formation and Cell Death Caused by the Truncated Machado–Joseph Disease Gene Product with an Expanded Polyglutamine Stretch , 2002, Neurobiology of Disease.
[52] J. Grosclaude,et al. In Vitro and In Vivo Neurotoxicity of Prion Protein Oligomers , 2007, PLoS pathogens.